Toronto psychiatrist Madeline Li, MD, PhD, is running the only registered study to investigate ketamine specifically for the treatment of depression in cancer patients.
Abstract: Managing neuropathic pain in patients with advanced cancer can be challenging: it often requires an adjuvant analgesic and what works for one person may not work for another. Pain that is unresponsive to pharmacological approaches may require interventional procedures that are not usual in pain management. The effect of neuropathic cancer pain on patients is multidimensional and requires a multidisciplinary approach. Nurses play a key role in assessing the severity of the pain and its impact on quality of life, along with managing treatments.
This study will evaluate the efficacy of a recorded hypnosis intervention in reducing chronic pain among cancer survivors and will explore its biological and psychological mechanisms.